Search - tctmd.com

Displaying 181 - 200 of 479

Sort: Relevancy | Date

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Daily News

IVUS Guidance Beneficial for Diffuse Lesions in the Modern Stent Era

Todd Neale

March 22, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Role of OCT in Evaluation and treatment of In Stent Restenosis

Presenter: Andrew Lituchy

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presenter: Ajay J. Kirtane

March 10, 2016

News Daily News

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

L.A. McKeown

March 08, 2016

News Daily News

Los SLF de Nueva Generación Con Tratamiento Antiplaquetario Doble Abreviado Superan a los SMD en Pacientes de Alto Riesgo Hemorrágico

L.A. McKeown

March 08, 2016

News Daily News

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Michael O'Riordan

February 23, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

Presentation JIM 2016

BRS complication case examples: thrombosis, intraluminal scaffold dismantling, neoatherosclerosis, restenosis and more

Presenter: Yoshinobu Onuma

February 10, 2016

Presentation JIM 2016

Session III - BRS Cases for High-risk Patients and Challenging Anatomy In-stent restenosis

Presenter: Manel Sabaté

February 09, 2016

Presentation ISET 2016

Treatment Strategies for Carotid In-Stent Restenosis

Presenter: D. Chris Metzger

February 07, 2016

News Daily News

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

L.A. McKeown

February 03, 2016

News Features

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

Michael O'Riordan

January 06, 2016

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Industry News

Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis

November 12, 2015

News Conference News AHA 2015

IVUS Tops Angiography for Guiding DES Implantation in Long Lesions

Todd Neale

November 09, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

Advertisement

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

IVUS Guidance Beneficial for Diffuse Lesions in the Modern Stent Era

Role of OCT in Evaluation and treatment of In Stent Restenosis

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Newer-Generation DES With Abbreviated DAPT Bests BMS in Patients at High Risk for Bleeding

Los SLF de Nueva Generación Con Tratamiento Antiplaquetario Doble Abreviado Superan a los SMD en Pacientes de Alto Riesgo Hemorrágico

Increased Risk of Device Thrombosis With Bioresorbable Scaffold, but Some Say Risks Can Be Mitigated

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

BRS complication case examples: thrombosis, intraluminal scaffold dismantling, neoatherosclerosis, restenosis and more

Session III - BRS Cases for High-risk Patients and Challenging Anatomy In-stent restenosis

Treatment Strategies for Carotid In-Stent Restenosis

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

Increased Early Risk of Stent Thrombosis With the Absorb Bioresorbable Scaffold

First Patients Enrolled in the Gore RELINE MAX Clinical Study

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Spectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter, Only Indicated Atherectomy Device for Treatment of In-Stent Restenosis

IVUS Tops Angiography for Guiding DES Implantation in Long Lesions

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content